Title : Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.

Pub. Date : 2015

PMID : 26098203






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Despite the successful clinical use of imatinib mesylate, a selective receptor tyrosine kinase (RTK) inhibitor that targets KIT, PDGFRA and BCR-ABL, we still do not have treatment for the long-term control of advanced GIST. Imatinib Mesylate ret proto-oncogene Homo sapiens
2 Despite the successful clinical use of imatinib mesylate, a selective receptor tyrosine kinase (RTK) inhibitor that targets KIT, PDGFRA and BCR-ABL, we still do not have treatment for the long-term control of advanced GIST. Imatinib Mesylate ret proto-oncogene Homo sapiens